2023-506117-22-00已完成1 期
A study to assess the effect of CC-95251 alone and in combination with anti-cancer drugs in subjects with Acute Myeloid Leukemia and Myelodysplastic Syndromes
Celgene Corp., Celgene Corp.18 个研究点 分布在 5 个国家目标入组 153 人开始时间: 2024年2月1日最近更新:
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 153
- 试验地点
- 18
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 65+ years（18-64 Years, 65+ Years）
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
GSM-CT
Scientific
Celgene Corp.
研究点 (18)
Loading locations...
相似试验
已完成
1 期
A Trial to Determine the Safety of CC-93269, an Antibody, in People who have Multiple Myeloma That Has Returned After a Period of Treatment And is not Responsive After Treatment.2023-506564-14-00Celgene International II S.a.r.l.112
招募中
1 期
A Study to Evaluate CC-486 in Participants With Moderate or Severe Hepatic Impairment Compared With Normal Hepatic Function in Cancer Participants2023-503427-26-00Celgene Corp.14
已完成
1 期
A research study on the effects of NNC0537-1482 in healthy individuals when injected under the skin.Heart Failure2024-514431-18-00Novo Nordisk A/S56
已完成
1 期
A Phase 1 Randomized Study to Evaluate the Effect of Food on the Bioavailability of BMS-986158 in Participants with Advanced Solid Tumors.2023-506661-65-00Bristol-Myers Squibb Services Unlimited Company40
招募中
1 期
A Phase 1 study of GSK5764227 in participants with advanced solid tumors2024-513663-10-01Glaxosmithkline Research & Development Limited, Glaxosmithkline Research & Development Limited112